Hyponatremia in cancer patients

Area of Science:

• Oncology
• Endocrinology
• Nephrology

Background:

• Hyponatremia is a frequent electrolyte disorder and poor prognostic factor in hospitalized cancer patients.
• Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is often misdiagnosed due to laboratory interpretation challenges.
• SIADH in cancer is frequently caused by ectopic arginine vasopressin (AVP) production, particularly in small cell lung cancer.

Purpose of the Study:

• To provide concise information for managing SIADH in oncology clinical practice.
• To highlight diagnostic challenges and therapeutic strategies for SIADH in cancer patients.

Main Methods:

• Review of literature on SIADH in oncology.
• Discussion of diagnostic criteria and interpretation of laboratory tests.
• Outline of therapeutic options including fluid restriction, hypertonic saline, and vaptans.

Main Results:

• SIADH results from water imbalance and serum sodium deficiency, often linked to ectopic AVP.
• Neurological symptoms vary based on the severity and rate of hyponatremia.
• Effective management requires accurate diagnosis and appropriate therapeutic interventions.

Conclusions:

• Accurate diagnosis of SIADH is crucial for effective management in cancer patients.
• Treatment strategies for SIADH vary based on presentation: hypertonic saline for acute, fluid restriction for chronic.
• Vaptans offer a targeted approach for euvolemic hyponatremia due to SIADH.